Location: Luxembourg
CIK: 0001053906 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.173B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CAVA | Cava Group Inc | 9,507,990 | $1.073B | 91.4% | $41.17 | +223.9% | COM | 148929102 |
| LXRX | Lexicon Pharmaceuticals Inc | 136,180,481 | $101M | 8.6% | $4.00 | -69.5% | COM NEW | 528872302 |